MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
7.65
-0.32
-4.02%
Pre Market: 7.67 +0.02 +0.26% 07:45 08/11 EDT
OPEN
7.79
PREV CLOSE
7.97
HIGH
8.27
LOW
7.61
VOLUME
1.08K
TURNOVER
0
52 WEEK HIGH
17.58
52 WEEK LOW
5.37
MARKET CAP
515.15M
P/E (TTM)
-1.5285
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DNA last week (0803-0807)?
Weekly Report · 1d ago
Etsy, Trade Desk, Energy Fuels, Ginkgo, Dropbox Trending
TipRanks · 3d ago
Ginkgo Bioworks Q2 Earnings Call Highlights
NASDAQ · 3d ago
Ginkgo Bioworks Holdings Cut to Hold From Buy by TD Cowen
Dow Jones · 3d ago
Ginkgo Bioworks Holdings Price Target Cut to $9.00/Share From $12.00 by TD Cowen
Dow Jones · 3d ago
TD Cowen Downgrades Ginkgo Bioworks Holdings to Hold, Lowers Price Target to $9
Benzinga · 3d ago
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), InflaRx (IFRX) and Tectonic Therapeutic (TECX)
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)
TipRanks · 5d ago
More
About DNA
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.